Biosimilar vs originator: as switches loom in the US, once again it’s really hard to say we see any differences in drug survival for our RA patients These data from forced switching in BC, Canada are just like the others - biosimilars are business as usual. POS0567 #EULAR2023 https://t.co/Ebl1hTM4qE

Ongoing work to #classify #inflammatory #arthritis in Pts using #check #point #inhibitors. A 1st step to study the etiology of immune changes from these life prolonging medications #EULAR2023 @RheumNow https://t.co/Bv1q8IphqF

• https://twitter.com/drdavidliew/status/1663889739307704324

Different B cell depleting agents! #Eular2023 https://t.co/GsmdIHgOcl

Can #machine #learning replace #rheumatologists? OP0190 #EULAR23 #Machine learning can help determine who will develop #rheumatoidarthritis in Pts with #arthralgia but the real study could be ask #clinician the #probability of RA and do #AI and see comparative accuracy @RheumNow

There are lots of reasons why axSpA treatments fail for patients. And as rheumatologists, we can’t just prescribe and walk away - we need to address each in turn, for our patients’ sake #EULAR2023 @RheumNow https://t.co/hzo57BaEXw

#Precision medicine in #SLE #Interferon is not a good predictor of remission as it takes a LONG time to normalize in #Lupus @RheumNow @eular_org #EULAR2023 abst#OP https://t.co/JkWnk94bHu

RheumNow’s expanded coverage of the #EULAR2023 Annual meeting is sponsored in part by Bristol Myers Squibb. All content is chosen by RheumNow and its Faculty.

EULAR opens their meeting as a leader in #Rheumatology education and >5800 abstracts. A warm welcome for #EULAR2023 from the president! ⁦@RheumNow⁩ Opening ceremony. Impressive! https://t.co/RLQLQGOA8K

When does RA get complicated? Many things can burden our patients, making their RA difficult to treat #EULAR2023 @RheumNow https://t.co/FM1UCNbmKr

#EULAR2023 https://t.co/KwFnvzdNzz

Researchers@of tomorrow. Winners of EULAR basic and epi and clinical abstract awards - young leaders! ⁦@RheumNow⁩ #EULAR2023 ⁦@eular_org⁩ https://t.co/VsV5aQpxjs

Delighted to be reporting for @RheumNow LIVE from Milan 🇮🇹 #EULAR2023 alongside my esteemed colleagues @drdavidliew @Janetbirdope @jeffsparks @synovialjoints @AurelieRheumo @bella_mehta 🙌🏻 Do follow us for Congress coverage 😃 https://t.co/tmD4vVWnQk

#EULAR2023 Please find my first article on Congress Preview of Promising New Therapies in #lupus #SLE @RheumNow https://t.co/SFvhsP8QWO https://t.co/m5UwBGCXFB

• Promising new therapies in SLE: preview of EULAR23 | RheumNow

A full house for the #EULAR2023 Opening session @eular_org setting the tone for an exciting few days to come! @RheumNow https://t.co/bZSIL78mU6

Tuesday Night Rheumatology: POD 4: Rheumatoid Arthritis: Decisive Therapeutics https://t.co/GzLE2XLe1q

• https://twitter.com/i/broadcasts/1YqxoAdvbjBGv